Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 70/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Key Takeaway: Dr. Reddy's Laboratories Ltd. has announced the allotment of 12,322 equity shares following the exercise of stock options under its Employee Stock Option Plans. This decision was approved by the Nomination, Governance and Compensation Committee and was executed on August 24, 2023. The shares were allotted at various prices, with some shares having no premium, and they rank pari passu with existing shares. Such allotments can be indicative of the company's commitment to employee engagement and potential growth.

Market Sentiment Analysis

POSITIVE FACTORS

  • Allotment of equity shares indicates confidence in employee contributions.
  • Exercise of stock options can enhance employee satisfaction and retention.
  • Increased share capital reflects a potential growth in company valuation.

Full Press Release Details

National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE Ltd. (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Sub: Allotment of Equity Shares on exercise
of Stock Options under ESOPs
This is to inform you that the Nomination, Governance
and Compensation Committee of the Board of Directors of the Company has approved the allotment of 12,322 equity shares of Rs. 5/- each
of the Company, fully paid up, on August 24, 2023, to employees pursuant to exercise of their Stock Options, as per the following details:
Further, please find enclosed the details as required
under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
This is for your information and records.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer & Head-CSR
Details under Regulation 10(c) of the SEBI (Share
Based Employee Benefits and Sweat Equity) Regulations, 2021
1 Company name and address of Registered Office: Dr. Reddy's Laboratories Limited 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500034
2 Name of the Stock Exchanges on which the company's shares are listed: BSE Limited National Stock Exchange of India Limited New York Stock Exchange Inc. (ADRs) NSE IFSC Limited (ADRs)
3 Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange: The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
4 Filing Number, if any: NA
5 Title of the Scheme pursuant to which shares are issued, if any: Dr. Reddy's Employees Stock Option Scheme, 2002 and Dr. Reddy's Employees ADR Stock Option Scheme, 2007
6 Kind of security to be listed: Equity Shares
7 Par value of the shares: Rs. 5/-
8 Date of issue of shares: August 24, 2023 (Date of allotment on exercise)
9 Number of shares issued: 12,322 equity shares
10 Share Certificate No., if applicable: NA
11 Distinctive number of the share, if applicable: 213161964 to 213174285
12 ISIN Number of the shares if issued in Demat: INE089A01023
13 Exercise price per share: (a) 8,742 equity shares exercised at Rs. 5/- per share (b) 2,025 equity shares exercised at Rs.2,607/- per share (c) 975 equity shares exercised at Rs.2,814/- per share (d) 580 equity shares exercised at Rs.3,679/- per share
14 Premium per share: (a) 8,742 equity shares - Nil (b) 2,025 equity shares - Rs.2,602/- per share (c) 975 equity shares - Rs. 2,809/- per share (d) 580 equity shares - Rs.3,674/- per share
15 Total Issued shares after this issue: 16,67,71,681 (*)
16 Total Issued share capital after this issue: Rs. 83,38,58,405 /-
17 Details of any lock-in on the shares: NA
18 Date of expiry of lock-in: NA
19 Whether shares identical in all respects to existing shares if not, when will they become identical? Yes, the shares rank pari passu with the existing shares
20 Details of listing fees, if payable: NA
(*) Total paid up capital after this issue: 166,771,481,
i.e., Rs. 833,857,405 (difference of 200 due to forfeited shares of Rs. 5/- each in September 1988 on account of non-payment of allotment

Frequently Asked Questions

How many equity shares were allotted?

A total of 12,322 equity shares were allotted on August 24, 2023.

What is the par value of the shares issued?

The par value of the shares issued is Rs. 5/- each.

Which stock exchanges list Dr. Reddy's shares?

Dr. Reddy's shares are listed on BSE, NSE, and NYSE.

What is the exercise price per share?

The exercise price varies, starting from Rs. 5/- to Rs. 3,679/-.

Are the new shares identical to existing shares?

Yes, the new shares are identical to existing shares and rank pari passu.

Last updated: Aug 24, 2023